Shanghai Junshi Biosciences Co Ltd
SSE:688180
Shanghai Junshi Biosciences Co Ltd
Cost of Revenue
Shanghai Junshi Biosciences Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Junshi Biosciences Co Ltd
SSE:688180
|
Cost of Revenue
-¥634.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-216%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-70%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cost of Revenue
-¥1.1B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cost of Revenue
-¥992.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cost of Revenue
-¥39.6B
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
-63%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cost of Revenue
-¥99.9m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Junshi Biosciences Co Ltd's Cost of Revenue?
Cost of Revenue
-634.4m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Cost of Revenue amounts to -634.4m CNY.
What is Shanghai Junshi Biosciences Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-216%
Over the last year, the Cost of Revenue growth was -21%. The average annual Cost of Revenue growth rates for Shanghai Junshi Biosciences Co Ltd have been -19% over the past three years , -216% over the past five years .